MedTrace Logo

Effect of Oxalate and Urate Metabolism on CKD Evolution

NCT04399915 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2020-05-22

No results posted yet for this study

Summary

The current study primarily aimed to characterize the oxalate and uric acid metabolism in CKD patients and to analyze its association with renal survival prognosis. Secondarily, the study is planned to determine whether hyperoxalemia and hyperuricemia are independent risk factors for cardiovascular events and mortality.

Conditions

  • CKD
  • ESRD
  • Hyperuricemia
  • Oxaluria

Sponsors & Collaborators

  • The Institute of Nephrology of the Academy of Medical Sciences of Ukraine

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-10
Primary Completion
2021-12-31
Completion
2024-12-31

Countries

  • Ukraine

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04399915 on ClinicalTrials.gov